Former Investment Representative with large private firm with seat on NYSE. BBA degree in Marketing. Now working as a Rail Traffic Controller for one of the nations largest railroads.
Have been investing in stocks for over 25 years. Consider myself an investor, not a trader. Believe day trading is a losers game and that most who partake are wasting their lives and will end up broke. Most holdings held for months, some for years.
Favorite companies to invest in include: 1) Companies that are experiencing increases in institutional ownership and/or reductions in short positions (and especially if "analyst" continue to bash the stock while this is occurring, wink wink), 2) Biotechnology companies that have sold off dramatically after receiving FDA approval as traders lose patience with the speed of the drugs roll-out or ramp up, 3) Companies on the cusp of profitability but whose price does not yet reflect it, 4) Established companies whose shares have been beat down relentlessly but whose price has put in a solid (and preferably tested) base that's now rising at some price not too far removed from their 52-wk lows, 5) Companies that multiple hedge funds have started to take large positions in, and 6) Companies that can raise money cheaply without diluting shareholders into oblivion.
Avoid: 1) Stocks trading under $1.00, 2) Stocks rising in conjunction with spikes in message board chatter, buyout rumors, or because they are being pumped somewhere, and 3) Stocks whose EPS are the inverse of their share price... or even close.
Jerry Yang is a contract equity research analyst for LifeSci Advisors (New York, NY) and a CFA Level III candidate. Ning has over 10-year R&D experience in biotech, during which, he published over 10 papers in peer-review journals or conference proceedings and filed 4 patents. He was a key contributor to three products from initial design to or close to final product launch. Prior to his professional career in healthcare, Jerry received a PhD in biomedical engineering.
Swing Trading mostly tech stocks since 2007, with a critical eye to spot bs claims, and considering opportunities to short using short-term put options, with small account size < 25k. Goals: grow account size while minimizing risk using tech analysis to set entrance and exit levels, using candlestick and slow stochastics to forecast short term trading activity less than 5 days timeframe.